Michael Adu‐Frimpong

Eng koʻp iqtibos qilingan asarlar

1. The characterisation, pharmacokinetic and tissue distribution studies of TPGS modified myricetrin mixed micelles in rats201911 iqtibos
2. Preparation, characterization, pharmacokinetics and anti-hyperuricemia activity studies of myricitrin-loaded proliposomes201911 iqtibos
3. Preparation, Physical Characterization, Pharmacokinetics and Anti-Hyperglycemic Activity of Esculetin-Loaded Mixed Micelles20229 iqtibos
4. Hyperoside-loaded TPGs/mPEG-PDLLA self-assembled polymeric micelles: preparation, characterization and <i>in vitro</i>/<i>in vivo</i> evaluation20227 iqtibos
5. Preparation, in vitro and in vivo evaluation of isoliquiritigenin-loaded TPGS modified proliposomes20196 iqtibos
6. [6]-Shogaol/β-CDs inclusion complex: preparation, characterisation, <i>in vivo</i> pharmacokinetics, and <i>in situ</i> intestinal perfusion study20196 iqtibos
7. Enhancement of Oral Bioavailability and Anti-hyperuricemic Activity of Isoliquiritigenin via Self-Microemulsifying Drug Delivery System20195 iqtibos
8. Pinocembrin polymeric micellar drug delivery system: preparation, characterisation and anti-hyperuricemic activity evaluation20225 iqtibos
9. SMEDDS for improved oral bioavailability and anti-hyperuricemic activity of licochalcone A20213 iqtibos
10. Enhanced oral bioavailability and anti‐hyperuricemic activity of liquiritin via a self‐nanoemulsifying drug delivery system20213 iqtibos